-+ 0.00%
-+ 0.00%
-+ 0.00%

Atea Pharmaceuticals Director Bruce Polsky Reports Sale of $168,094.9506 in Common Shares

PUBT·11/19/2026 02:00:47
Listen to the news
Atea Pharmaceuticals Director Bruce Polsky Reports Sale of $168,094.9506 in Common Shares
  • Atea Pharmaceuticals director Bruce Polsky sold 41,226 common shares during November 16-18, 2026.
  • During the same period, he exercised stock options for 75,000 common shares at $1.24 per share.
  • Sale prices were $4.2683 on November 16, $4.0316 on November 17 and $3.9502 on November 18.
  • His direct common stock holdings totaled 158,580 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-467490), on November 18, 2026, and is solely responsible for the information contained therein.